Viveve Medical Stock Analysis

Viveve Pink Sheet Analysis Notes

The book value of the company was at this time reported as 0.11. The company recorded a loss per share of 2.55. Viveve Medical last dividend was issued on the 2nd of December 2020. The entity had 1:10 split on the 2nd of December 2020. Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado. Viveve Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 47 people.The quote for Viveve Medical is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call Scott Durbin at 720 696 8100 or visit https://www.viveve.com.

Viveve Medical Investment Alerts

Viveve Medical Thematic Classifications

Viveve Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.08 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Viveve Medical's market, we take the total number of its shares issued and multiply it by Viveve Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 31st of January, Viveve Medical has the Risk Adjusted Performance of 0.0949, coefficient of variation of 854.36, and Variance of 9992.52. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Viveve Medical, as well as the relationship between them. Please validate Viveve Medical risk adjusted performance, variance, as well as the relationship between the Variance and kurtosis to decide if Viveve Medical is priced more or less accurately, providing market reflects its prevalent price of 2.0E-4 per share. As Viveve Medical appears to be a penny stock we also recommend to double-check its information ratio numbers.

Viveve Medical Price Movement Analysis

Viveve Medical Outstanding Bonds

Viveve Medical Predictive Daily Indicators

Viveve Medical Forecast Models

Viveve Medical's time-series forecasting models are one of many Viveve Medical's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Viveve Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Viveve Medical Debt to Cash Allocation

Viveve Medical currently holds 5.12 M in liabilities with Debt to Equity (D/E) ratio of 1.12, which is about average as compared to similar companies. Viveve Medical has a current ratio of 1.29, suggesting that it may not have the ability to pay its financial obligations when due. Debt can assist Viveve Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Viveve Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Viveve Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Viveve to invest in growth at high rates of return. When we think about Viveve Medical's use of debt, we should always consider it together with cash and equity.

Viveve Medical Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Viveve Medical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Viveve Medical, which in turn will lower the firm's financial flexibility.

Viveve Medical Corporate Bonds Issued

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Viveve Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Viveve shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Viveve Medical. By using and applying Viveve Pink Sheet analysis, traders can create a robust methodology for identifying Viveve entry and exit points for their positions.

When running Viveve Medical's price analysis, check to measure Viveve Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viveve Medical is operating at the current time. Most of Viveve Medical's value examination focuses on studying past and present price action to predict the probability of Viveve Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viveve Medical's price. Additionally, you may evaluate how the addition of Viveve Medical to your portfolios can decrease your overall portfolio volatility.